Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CRH Medical Corporation stock logo
CRHM
CRH Medical
$3.99
$3.99
$1.66
$4.01
$285.76MN/A1.04 million shs388,486 shs
InnovAge Holding Corp. stock logo
INNV
InnovAge
$3.91
+2.9%
$4.54
$3.80
$8.05
$531.37M0.1523,521 shs8,567 shs
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$0.00
$0.03
$6.74
$4.17M0.457.75 million shsN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$20.78
+2.3%
$19.24
$10.31
$21.45
$623.61M2.06142,978 shs89,016 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00%0.00%0.00%0.00%0.00%
InnovAge Holding Corp. stock logo
INNV
InnovAge
-4.76%-5.00%-10.38%-35.15%+379,999,900.00%
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
0.00%0.00%0.00%-99.32%-98.56%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
-1.93%+2.11%+4.15%+32.23%+47.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.8441 of 5 stars
3.02.00.00.01.70.00.6
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
1.6554 of 5 stars
1.33.00.00.01.02.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
2.00
Hold$6.5066.24% Upside
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.67
Moderate Buy$18.75-9.77% Downside

Current Analyst Ratings

Latest PNTG, CRHM, PEAR, and INNV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/13/2024
InnovAge Holding Corp. stock logo
INNV
InnovAge
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$7.00 ➝ $6.00
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$18.00 ➝ $22.00
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$16.00 ➝ $21.00
2/8/2024
InnovAge Holding Corp. stock logo
INNV
InnovAge
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
$688.09M0.77N/AN/A$2.23 per share1.75
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
$12.69M0.00N/AN/A$0.22 per share0.00
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$544.89M1.14$0.79 per share26.47$4.86 per share4.28

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/A0.00N/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$40.67M-$0.25N/A391.00N/A-4.38%-10.53%-5.69%5/7/2024 (Confirmed)
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
-$75.49M-$0.22N/AN/AN/A-594.70%-217.85%-95.20%N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$13.38M$0.4447.2324.162.182.46%12.78%3.36%5/6/2024 (Confirmed)

Latest PNTG, CRHM, PEAR, and INNV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$0.04N/A+$0.04N/AN/AN/A  
5/6/2024N/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.15N/A-$0.15N/AN/AN/A  
2/28/202412/31/2023
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.19$0.18-$0.01$0.22$136.79 million$145.95 million      
2/5/2024Q2 2024
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$0.03-$0.03N/A-$0.03$181.51 million$188.90 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
N/AN/AN/AN/AN/A
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.26
1.27
1.27
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
N/A
1.48
1.48
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.44
1.12
1.12

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
12.26%
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
71.17%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%

Insider Ownership

CompanyInsider Ownership
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.41%
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
30.70%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A71.62 millionN/ANot Optionable
InnovAge Holding Corp. stock logo
INNV
InnovAge
2,100135.90 million135.34 millionOptionable
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
300142.74 million98.92 millionNot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5,79130.01 million28.27 millionOptionable

PNTG, CRHM, PEAR, and INNV Headlines

SourceHeadline
Transactions: ShiftMed Buys CareerStaff Unlimited; Nova Leap Purchases Massachusetts ProviderTransactions: ShiftMed Buys CareerStaff Unlimited; Nova Leap Purchases Massachusetts Provider
homehealthcarenews.com - April 26 at 6:30 PM
Pennant Announces First Quarter 2024 Earnings Release and CallPennant Announces First Quarter 2024 Earnings Release and Call
globenewswire.com - April 23 at 4:02 PM
The Pennant Group, Inc. (PNTG)The Pennant Group, Inc. (PNTG)
finance.yahoo.com - April 23 at 9:01 AM
The Pennant Group (NASDAQ:PNTG) Reaches New 12-Month High at $21.00The Pennant Group (NASDAQ:PNTG) Reaches New 12-Month High at $21.00
marketbeat.com - April 22 at 4:46 PM
Cornercap Investment Counsel Inc. Acquires Shares of 42,851 The Pennant Group, Inc. (NASDAQ:PNTG)Cornercap Investment Counsel Inc. Acquires Shares of 42,851 The Pennant Group, Inc. (NASDAQ:PNTG)
marketbeat.com - April 17 at 6:45 AM
What Makes The Pennant Group, Inc. (PNTG) a Strong Momentum Stock: Buy Now?What Makes The Pennant Group, Inc. (PNTG) a Strong Momentum Stock: Buy Now?
zacks.com - April 8 at 1:01 PM
The Pennant Group (NASDAQ:PNTG) Hits New 12-Month High at $20.54The Pennant Group (NASDAQ:PNTG) Hits New 12-Month High at $20.54
marketbeat.com - April 3 at 4:51 PM
The Pennant Group, Inc. (NASDAQ:PNTG) Short Interest Up 27.5% in MarchThe Pennant Group, Inc. (NASDAQ:PNTG) Short Interest Up 27.5% in March
marketbeat.com - April 1 at 3:48 PM
The Pennant Group, Inc.s (NASDAQ:PNTG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?The Pennant Group, Inc.'s (NASDAQ:PNTG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
finance.yahoo.com - March 28 at 11:12 AM
PNTG May 2024 17.500 putPNTG May 2024 17.500 put
finance.yahoo.com - March 26 at 2:07 PM
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services ConferencePennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
globenewswire.com - March 12 at 11:22 AM
Heres Why The Pennant Group, Inc. (PNTG) is a Great Momentum Stock to BuyHere's Why The Pennant Group, Inc. (PNTG) is a Great Momentum Stock to Buy
zacks.com - March 7 at 1:01 PM
What Makes The Pennant Group, Inc. (PNTG) a New Buy StockWhat Makes The Pennant Group, Inc. (PNTG) a New Buy Stock
zacks.com - March 5 at 1:01 PM
Earnings call: Pennant Group exceeds Q4 earnings, eyes growth in 2024Earnings call: Pennant Group exceeds Q4 earnings, eyes growth in 2024
investing.com - March 2 at 11:41 PM
Pennant Group, Inc. (PNTG) Q4 2023 Earnings Call TranscriptPennant Group, Inc. (PNTG) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 2 at 6:40 PM
Pennant Group, Inc.: Pennant Reports Fourth Quarter and Fiscal Year 2023 ResultsPennant Group, Inc.: Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
finanznachrichten.de - March 1 at 5:36 PM
Pennant Acquires Two Senior Living Communities in UtahPennant Acquires Two Senior Living Communities in Utah
globenewswire.com - March 1 at 3:58 PM
The Pennant Group, Inc. (NASDAQ:PNTG) Q4 2023 Earnings Call TranscriptThe Pennant Group, Inc. (NASDAQ:PNTG) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 12:36 PM
Pennant Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsPennant Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - March 1 at 7:35 AM
The Pennant Group, Inc. (PNTG) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesThe Pennant Group, Inc. (PNTG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - February 28 at 7:31 PM
Pennant Group Inc (PNTG) Reports Strong Earnings Growth in Q4 and Fiscal Year 2023Pennant Group Inc (PNTG) Reports Strong Earnings Growth in Q4 and Fiscal Year 2023
ca.finance.yahoo.com - February 28 at 5:55 PM
Pennant GAAP EPS of $0.14 misses by $0.06, revenue of $146M beats by $9.57MPennant GAAP EPS of $0.14 misses by $0.06, revenue of $146M beats by $9.57M
msn.com - February 28 at 5:55 PM
Pennant Reports Fourth Quarter and Fiscal Year 2023 ResultsPennant Reports Fourth Quarter and Fiscal Year 2023 Results
globenewswire.com - February 28 at 4:05 PM
Ahead of The Pennant Group, Inc. (PNTG) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsAhead of The Pennant Group, Inc. (PNTG) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
zacks.com - February 26 at 10:21 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CRH Medical logo

CRH Medical

NYSE:CRHM
InnovAge logo

InnovAge

NASDAQ:INNV
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Pear Therapeutics logo

Pear Therapeutics

NASDAQ:PEAR
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
The Pennant Group logo

The Pennant Group

NASDAQ:PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.